Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...

GlobalData’s senior medical analyst says the ban will add to a downward trend for Illumina in the Chinese market.

being held in Florida—where the DNA sequencing giant is set to unveil more details and demonstrations—and follows up on Illumina’s recent expansions into proteomics and single-cell analysis.

The advancements include genomics, spatial transcriptomics, single cell analysis ... of complex data sets. Illumina's announcements were made at the Advances in Genome Biology and Technology ...

A clear picture of Illumina's perception among financial experts is painted with a thorough analysis of recent analyst ... technology enables whole genome sequencing in humans and other large ...

Another early user, Nick Banovich, PhD, associate professor and director, Bioinnovation and Genome ... platform, Illumina Connected Multiomics (ICM). ICM is a cloud-based multimodal analysis ...

Brown Advisors, an investment management company, released its “Brown Advisors Global Leaders Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. In the letter ...

"Illumina has set the standard in whole genome sequencing, and now ... 25B flow cell and DRAGEN analysis software creates a seamless end-to-end workflow enabling the high-throughput processing of ...

U.S. President Donald Trump has issued a memorandum directing federal agencies to restrict inbound and outbound investments ...